Moderna Inc MRNA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 3:39 PM EDT
123.20quote price arrow up+0.97 (+0.79%)
Volume
3,154,287
52 week range
115.61 - 403.30
Loading...
  • Open123.58
  • Day High126.29
  • Day Low121.82
  • Prev Close122.23
  • 52 Week High403.30
  • 52 Week High Date09/28/21
  • 52 Week Low115.61
  • 52 Week Low Date06/13/22

Key Stats

  • Market Cap48.196B
  • Shares Out391.20M
  • 10 Day Average Volume5.87M
  • Dividend-
  • Dividend Yield-
  • Beta1.69
  • YTD % Change-51.56

KEY STATS

  • Open123.58
  • Day High126.29
  • Day Low121.82
  • Prev Close122.23
  • 52 Week High403.30
  • 52 Week High Date09/28/21
  • 52 Week Low115.61
  • 52 Week Low Date06/13/22
  • Market Cap48.196B
  • Shares Out391.20M
  • 10 Day Average Volume5.87M
  • Dividend-
  • Dividend Yield-
  • Beta1.69
  • YTD % Change-51.56

RATIOS/PROFITABILITY

  • EPS (TTM)32.80
  • P/E (TTM)3.76
  • Fwd P/E (NTM)7.87
  • EBITDA (TTM)15.945B
  • ROE (TTM)113.86%
  • Revenue (TTM)22.995B
  • Gross Margin (TTM)82.29%
  • Net Margin (TTM)61.12%
  • Debt To Equity (MRQ)4.24%

EVENTS

  • Earnings Date11/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

Pro Picks: Watch all of Tuesday's big stock calls on CNBC
VIDEO6:5106:51
Pro Picks: Watch all of Tuesday's big stock calls on CNBC

Profile

MORE
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases...
Noubar Afeyan Ph.D.
Non-Executive Independent Chairman of the Board, Co-Founder
Stephane Bancel
Chief Executive Officer, Director
Stephen Hoge M.D.
President
James Mock
Chief Financial Officer
Juan Andres
Chief Technical Operations and Quality Officer
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
BNTX
BioNTech SE
134.25+3.96+3.04%
REGN
Regeneron Pharmaceuticals Inc
709.00+13.99+2.01%
BIIB
Biogen Inc
275.82+78.03+39.45%
ILMN
Illumina Inc
200.69+13.85+7.41%
ALNY
Alnylam Pharmaceuticals Inc
210.69+8.08+3.99%